Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia

Published:2023-03 Issue: Volume:21 Page:499-510
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Xia Yifeng,An Jingnan,Li Jiaying,Gu Wenxing,Zhang Yifan,Zhao Songsong,Zhao Cenzhu,Xu Yang,Li Bin,Zhong Zhiyuan,Meng Fenghua

Funder

Natural Science Foundation of Jiangsu Province

U.S. Food and Drug Administration

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Biotechnology

Reference51 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Two decades of targeted therapies in acute myeloid leukemia;Cucchi;Leukemia,2021

3. Heterogeneity in refractory acute myeloid leukemia;Horibata;P. Natl. Acad. Sci. USA,2019

4. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL);Maschmeyer;Leukemia,2019

5. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives;Zhong;Signal Transduct. Targeted Ther.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia;Small;2024-06-27

2. Advantages of nanomedicine over the conventional treatment in Acute myeloid leukemia;Journal of Biomaterials Science, Polymer Edition;2023-12-19

3. Integrin-targeting disulfide-crosslinked micellar docetaxel eradicates lung and prostate cancer patient-derived xenografts;Acta Biomaterialia;2023-10

4. Polo-like kinase 1 promotes pulmonary hypertension;Respiratory Research;2023-08-19

5. Exogenous Antigen Upregulation Empowers Antibody Targeted Nanochemotherapy of Leukemia;Advanced Materials;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3